Professor Tommy B Andersson
Senior Principal Scientist
Paper presenting: Novel Microphysiological Multi-Organ Systems for Studies of Human Metabolic Diseases in Drug Discovery
Tommy B Andersson joined AstraZeneca 1993 where he has held several positions in Drug metabolism and Pharmacokinetic departments as well as in Clinical Pharmacology. He was also appointed Professor at Karolinska Institutet in Drug Metabolism 2003. He is now a Senior Principal Scientist at AstraZeneca R&D, Gothenburg, at Cardiovascular and Metabolic disease function and currently leading the development of microphysiological systems at the department. He has an excellent track-record of developing and executing strategic and operational plans across boundaries in complex global matrix organisations. Extensive experience in leading cross-functional problem solving groups delivering expert evaluations, plans and solutions. Strong scientific expertise with over 160 publications (H-index 56, over 9000 citations) and recognized as a key opinion leader in drug metabolism, disposition and toxicology.